Boston Scientific announces cardiac devices' debut in Europe

02/28/2008 | Boston Globe (tiered subscription model), The

Boston Scientific Corp. announced Thursday that doctors have started to use its implantable Cognis cardiac resynchronization therapy defibrillator and its Teligen implantable cardioverter defibrillator for the treatment of cardiac failure and sudden cardiac arrest in European patients.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC